NUTX vs. ATYR

Last updated Apr 1, 2026

Compare and contrast key facts about Nutex Health Inc (NUTX) and aTyr Pharma, Inc. (ATYR).

Performance

NUTX vs. ATYR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutex Health Inc (NUTX) and aTyr Pharma, Inc. (ATYR). The values are adjusted to include any dividend payments, if applicable.

NUTX vs. ATYR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
NUTX Nutex Health Inc	-42.27%	419.47%	17.37%	-90.53%	-95.25%
ATYR aTyr Pharma, Inc.	-0.40%	-78.37%	156.74%	-35.62%	-60.96%

Fundamentals

EPS NUTX : $14.78 ATYR : -$0.80
PS Ratio NUTX : 0.47 ATYR : 384.40
Total Revenue (TTM) NUTX : $875.26M ATYR : $190.00K
Gross Profit (TTM) NUTX : $444.28M ATYR : -$34.17M
EBITDA (TTM) NUTX : $274.31M ATYR : -$76.54M

Returns By Period

In the year-to-date period, NUTX achieves a -42.27% return, which is significantly lower than ATYR's -0.40% return.

NUTX

• 1D: 4.55%
• 1M: -13.96%
• YTD: -42.27%
• 6M: -8.01%
• 1Y: 102.08%
• 3Y*: -14.40%
• 5Y*: —
• 10Y*: —

ATYR

• 1D: 6.72%
• 1M: -18.73%
• YTD: -0.40%
• 6M: 8.12%
• 1Y: -74.17%
• 3Y*: -28.12%
• 5Y*: -29.78%
• 10Y*: -34.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NUTX vs. ATYR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUTX

NUTX Risk / Return Rank: 72
NUTX Sharpe Ratio Rank: 72
NUTX Sortino Ratio Rank: 79
NUTX Omega Ratio Rank: 74
NUTX Calmar Ratio Rank: 72
NUTX Martin Ratio Rank: 64

ATYR

ATYR Risk / Return Rank: 21
ATYR Sharpe Ratio Rank: 15
ATYR Sortino Ratio Rank: 29
ATYR Omega Ratio Rank: 29
ATYR Calmar Ratio Rank: 11
ATYR Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NUTX vs. ATYR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and aTyr Pharma, Inc. (ATYR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NUTX	ATYR	Difference
Sharpe ratio Return per unit of total volatility	0.88	-0.61	+1.50
Sortino ratio Return per unit of downside risk	1.99	-0.03	+2.01
Omega ratio Gain probability vs. loss probability	1.24	1.00	+0.24
Calmar ratio Return relative to maximum drawdown	1.54	-0.83	+2.38
Martin ratio Return relative to average drawdown	2.40	-1.16	+3.56
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NUTX vs. ATYR - Sharpe Ratio Comparison

The current NUTX Sharpe Ratio is 0.88, which is higher than the ATYR Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of NUTX and ATYR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NUTX	ATYR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.88	-0.61	+1.50
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.36	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.40	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.48	-0.46	-0.02

Correlation

The correlation between NUTX and ATYR is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NUTX vs. ATYR - Dividend Comparison

Neither NUTX nor ATYR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NUTX vs. ATYR - Drawdown Comparison

The maximum NUTX drawdown since its inception was -99.93%, roughly equal to the maximum ATYR drawdown of -99.83%. Use the drawdown chart below to compare losses from any high point for NUTX and ATYR.

Drawdown Indicators

	NUTX	ATYR	Difference
Max Drawdown Largest peak-to-trough decline	-99.93%	-99.83%	-0.10%
Max Drawdown (1Y) Largest decline over 1 year	-54.34%	-90.15%	+35.81%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.78%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.26%	—
Current Drawdown Current decline from peak	-98.42%	-99.80%	+1.38%
Average Drawdown Average peak-to-trough decline	-97.24%	-93.07%	-4.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.90%	64.91%	-30.01%

Volatility

NUTX vs. ATYR - Volatility Comparison

Nutex Health Inc (NUTX) has a higher volatility of 24.94% compared to aTyr Pharma, Inc. (ATYR) at 21.76%. This indicates that NUTX's price experiences larger fluctuations and is considered to be riskier than ATYR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NUTX	ATYR	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.94%	21.76%	+3.18%
Volatility (6M) Calculated over the trailing 6-month period	73.87%	61.00%	+12.87%
Volatility (1Y) Calculated over the trailing 1-year period	116.41%	121.55%	-5.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	135.16%	83.77%	+51.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	135.16%	85.40%	+49.76%

Financials